Date & Time
7:00 pm - 9:00 pm
Anthony Bossis, PhD
Psychospiritual and existential distress is often an integral component of end-of-life suffering. Clinical research demonstrates that patients diagnosed with advanced-stage cancer often experience hopelessness, despair, and a loss of meaning. For many, a cancer diagnosis initiates a search for meaning. The NYU Psilocybin Cancer Anxiety Project is exploring the potential benefits that a psilocybin-facilitated mystical experience may provide in helping individuals cultivate meaning, improve spiritual well-being, and experience a greater acceptance of the dying process with less anxiety.
Subjective features of a mystical experience include unity, sacredness, transcendence, and a greater connection to deeply felt positive emotions including that of love. Using a compound from hallucinogenic mushrooms, the psilocybin-facilitated mystical experience offers a novel therapeutic approach to promote transcendence, meaning, and an enhanced openness to the mystery of death. This evening workshop will review existential distress at the end of life and the potential transformative benefits learned from mystical experience. Clinical case vignettes from the FDA approved clinical trial at NYU will be presented.
An Evening Workshop
Friday, June 15, 2018, 7:00 – 9:00 pm
$55 (Members & Nonmembers) Early Bird $45 by 5/18
This course is also part of the Integrative Thanatology Certificate Program
New York Open Center
Anthony Bossis, Ph.D. is a clinical psychologist and Clinical Assistant Professor of Psychiatry at New York University School of Medicine. He was director of palliative care research, co-principal investigator, and a session guide for the NYU Psilocybin Cancer Anxiety Study and is Project Director for the NYU Psilocybin Religious Leaders Study. He maintains a private psychotherapy practice in NYC.